ArticleMolecular therapy. Oncology2025

TREM-1 as a novel immunotherapeutic target to treat pancreatic ductal adenocarcinoma.

Lina Gross et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.